Remedium Lifecare Ltd — Important, 25-08-2025: Company Update

Remedium Lifecare unveiled a 4-point strategy aimed at achieving 4X growth. This plan focuses on advanced manufacturing and CDMO expansion, global export growth into new markets, R&D excellence to accelerate product development, and product diversification across specialty chemicals and pharmaceuticals. The company reported a strong Q1, with Profit After Tax (PAT) of ₹4.65 Cr, a 327% surge from the ₹2.05 Cr loss in Q4 FY25. This Q1 PAT alone doubled the entire FY25 profit. Additionally, Remedium successfully completed its oversubscribed Rights Issue, raising ₹47.88 Cr, positioning it for consistent profitability and global reach.